Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease
- PMID: 23688662
- PMCID: PMC3837582
- DOI: 10.1016/j.amjmed.2013.01.035
Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease
Abstract
Background: Over the last 15 years, substantial advances have been made in the treatment of chronic obstructive pulmonary disease (COPD). Little information is available, however, on whether these treatments have resulted in reduced rates of hospitalization and acute exacerbations among COPD patients. This retrospective cohort study examined changes in hospitalization rates among Medicare beneficiaries with COPD from 1999 to 2008.
Methods: We analyzed data from 424,418 fee-for-service Medicare beneficiaries enrolled between 1999 and 2008 who were diagnosed with COPD. We examined temporal changes in the frequency of hospitalization and acute exacerbations among Medicare beneficiaries with COPD.
Results: Over the 10-year study period, the hospitalization rates for COPD patients--adjusted for age, sex, race, socioeconomic status, region, and number of comorbidities--decreased: from 131 to 107 per 100 person-years for all causes (P <.001); from 58 to 44 per 100 person-years for all respiratory causes (P <.001); and from 73 to 63 per 100 person-years for nonrespiratory causes (P <.001). There was no change in prevalence of COPD in the Medicare population over this time. Additionally, the percentage of COPD patients hospitalized with 2 or more acute exacerbations decreased from 5.5% to 4.3% over the 10-year study period (P <.001).
Conclusion: Between 1999 and 2008, hospitalization rates decreased substantially among Medicare beneficiaries diagnosed with COPD.
Copyright © 2013 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Patients with chronic obstructive pulmonary disease (COPD) are defined as: 1) 2 outpatient professional claims, with different dates of service, with a COPD diagnosis listed in any position; 2) one acute care hospitalization with a COPD diagnosis based on International Classification of Diseases, 9th Revision (ICD-9) code 491.x [chronic bronchitis], 492.x [emphysema], or 496 [chronic airway obstruction]) listed in primary position as a discharge diagnosis; or 3) one acute care hospitalization with respiratory failure (518.81, 518.82, 518.84) listed in the primary position as a discharge diagnosis and COPD listed as the secondary diagnosis.
For all 3 outcomes, linear contrast was tested in generalized estimating equation (GEE) model and yielded P values of < .0001.
Similar articles
-
Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.Ann Am Thorac Soc. 2015 Dec;12(12):1805-12. doi: 10.1513/AnnalsATS.201504-250OC. Ann Am Thorac Soc. 2015. PMID: 26394180 Free PMC article.
-
Racial Differences in 1-Year Mortality after Hospitalization for Chronic Obstructive Pulmonary Disease in the United States.Ann Am Thorac Soc. 2024 Apr;21(4):585-594. doi: 10.1513/AnnalsATS.202304-359OC. Ann Am Thorac Soc. 2024. PMID: 37943953
-
Participation in Pulmonary Rehabilitation by Veterans Health Administration and Medicare Beneficiaries After Hospitalization for Chronic Obstructive Pulmonary Disease.J Cardiopulm Rehabil Prev. 2018 Nov;38(6):406-410. doi: 10.1097/HCR.0000000000000357. J Cardiopulm Rehabil Prev. 2018. PMID: 30252780
-
Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.Am J Geriatr Pharmacother. 2012 Jun;10(3):201-10. doi: 10.1016/j.amjopharm.2012.04.002. Epub 2012 Apr 21. Am J Geriatr Pharmacother. 2012. PMID: 22521808
-
Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.BMJ Open Respir Res. 2020 Mar;7(1):e000483. doi: 10.1136/bmjresp-2019-000483. BMJ Open Respir Res. 2020. PMID: 32213535 Free PMC article.
Cited by
-
Hospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015.Biomed Res Int. 2018 Feb 8;2018:1060497. doi: 10.1155/2018/1060497. eCollection 2018. Biomed Res Int. 2018. PMID: 29581961 Free PMC article.
-
Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010.Int J Chron Obstruct Pulmon Dis. 2017 Sep 28;12:2787-2793. doi: 10.2147/COPD.S147968. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29026296 Free PMC article.
-
Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy.Int J Chron Obstruct Pulmon Dis. 2017 Jan 27;12:443-450. doi: 10.2147/COPD.S119390. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28184156 Free PMC article.
-
Rising total costs and mortality rates associated with admissions due to COPD exacerbations.Respir Res. 2016 Nov 14;17(1):149. doi: 10.1186/s12931-016-0469-6. Respir Res. 2016. PMID: 27842545 Free PMC article.
-
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.J Manag Care Spec Pharm. 2016 Apr;22(4):414-23. doi: 10.18553/jmcp.2016.22.4.414. J Manag Care Spec Pharm. 2016. PMID: 27023695 Free PMC article.
References
-
- Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–6. - PubMed
-
- Brown DW, Croft JB, Greenlund KJ, Giles WH. Deaths from chronic obstructive pulmonary disease—United States, 2000–2005. MMWR Morb Mortal Wkly Rep. 2008;57(45):1229–1232. - PubMed
-
- Halbert RJ, Isonaka S, George D, Igbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123:1684–1692. - PubMed
-
- Mannino DM. COPD: epidemiology, prevalence, morbidity, and mortality, and disease heterogeneity. Chest. 2002;121:121S–126S. - PubMed
-
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–1428. - PubMed
Publication types
MeSH terms
Grants and funding
- K05-CA134923/CA/NCI NIH HHS/United States
- K05 CA134923/CA/NCI NIH HHS/United States
- UL1TR000071/TR/NCATS NIH HHS/United States
- R01-AG033134/AG/NIA NIH HHS/United States
- UL1 TR000071/TR/NCATS NIH HHS/United States
- R01 HS020642/HS/AHRQ HHS/United States
- R01 AG033134/AG/NIA NIH HHS/United States
- P30 AG024832/AG/NIA NIH HHS/United States
- K23 AG038476/AG/NIA NIH HHS/United States
- K23AG038476/AG/NIA NIH HHS/United States
- 5P30AG024832/AG/NIA NIH HHS/United States
- UL1 RR029876/RR/NCRR NIH HHS/United States
- K08 AG031583/AG/NIA NIH HHS/United States
- R01-HS020642/HS/AHRQ HHS/United States
- U54RR026141/RR/NCRR NIH HHS/United States
- K08 AG31583/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
